XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Total Common Equity
Noncontrolling Interests in Subsidiaries
Balance at Oct. 31, 2022 $ 24,739 $ 73 $ 30,635 $ (6,208) $ 1,409 $ 25,909 $ (1,170)
Balance (in Shares) at Oct. 31, 2022   7,321          
Stock based compensation expense 5   5     5  
Vested share units granted to Directors 26   26     26  
Vested share units granted to Directors (in Shares)   2          
Stock options exercised 1,226 $ 1 1,225     1,226  
Stock options exercised (in Shares)   113          
Distributions to noncontrolling interests in subsidiaries (1,850)         (1,850)
Net income (loss) 46     419   419 (373)
Dividends declared (541)     (541)   (541)  
Net unrealized (gain) loss on interest rate swap contracts (450)       (450) (450)
Balance at Jan. 31, 2023 23,201 $ 74 31,891 (6,330) 959 26,594 (3,393)
Balance (in Shares) at Jan. 31, 2023   7,436          
Balance at Oct. 31, 2022 24,739 $ 73 30,635 (6,208) 1,409 25,909 (1,170)
Balance (in Shares) at Oct. 31, 2022   7,321          
Net income (loss) (1,086)            
Balance at Jul. 31, 2023 18,482 $ 74 32,074 (9,252) 1,241 24,137 (5,655)
Balance (in Shares) at Jul. 31, 2023   7,450          
Balance at Jan. 31, 2023 23,201 $ 74 31,891 (6,330) 959 26,594 (3,393)
Balance (in Shares) at Jan. 31, 2023   7,436          
Stock awards granted to directors 140   140     140  
Stock awards granted to directors (in Shares)   9          
Stock based compensation expense 5   5     5  
Stock options exercised 7   7     7  
Stock options exercised (in Shares)   1          
Distributions to noncontrolling interests in subsidiaries (204)         (204)
Net income (loss) (286)     97   97 (383)
Dividends declared (372)     (372)   (372)  
Net unrealized (gain) loss on interest rate swap contracts (107)       (107) (107)
Balance at Apr. 30, 2023 22,384 $ 74 32,043 (6,605) 852 26,364 (3,980)
Balance (in Shares) at Apr. 30, 2023   7,446          
Stock based compensation expense 1   1     1  
Stock options exercised 30   30     30  
Stock options exercised (in Shares)   4          
Distributions to noncontrolling interests in subsidiaries (1,241)           (1,241)
Net income (loss) (846)     (412)   (412) (434)
Dividends declared (2,235)     (2,235)   (2,235)  
Net unrealized (gain) loss on interest rate swap contracts 389       389 389  
Balance at Jul. 31, 2023 18,482 $ 74 32,074 (9,252) 1,241 24,137 (5,655)
Balance (in Shares) at Jul. 31, 2023   7,450          
Balance at Oct. 31, 2023 18,476 $ 74 32,074 (8,968) 1,336 24,516 (6,040)
Balance (in Shares) at Oct. 31, 2023   7,450          
Stock based compensation expense 1   1     1  
Distributions to noncontrolling interests in subsidiaries (180)         (180)
Net income (loss) (666)     (512)   (512) (154)
Dividends declared (372)     (372)   (372)  
Net unrealized (gain) loss on interest rate swap contracts (530)       (530) (530)
Net unrealized loss on investment in U.S. Treasury securities available-for-sale (7)       (7) (7)
Balance at Jan. 31, 2024 16,722 $ 74 32,075 (9,852) 799 23,096 (6,374)
Balance (in Shares) at Jan. 31, 2024   7,450          
Balance at Oct. 31, 2023 18,476 $ 74 32,074 (8,968) 1,336 24,516 (6,040)
Balance (in Shares) at Oct. 31, 2023   7,450          
Net income (loss) 16,068            
Balance at Jul. 31, 2024 31,822 $ 75 32,215 4,726 610 37,626 (5,804)
Balance (in Shares) at Jul. 31, 2024   7,458          
Balance at Jan. 31, 2024 16,722 $ 74 32,075 (9,852) 799 23,096 (6,374)
Balance (in Shares) at Jan. 31, 2024   7,450          
Stock awards granted to directors 141 $ 1 140     141  
Stock awards granted to directors (in Shares)   8          
Distributions to noncontrolling interests in subsidiaries (600)         (600)
Net income (loss) 399     533   533 (134)
Dividends declared (373)     (373)   (373)  
Net unrealized (gain) loss on interest rate swap contracts 257       257 257
Net unrealized loss on investment in U.S. Treasury securities available-for-sale (13)       (13) (13)
Balance at Apr. 30, 2024 16,533 $ 75 32,215 (9,692) 1,043 23,641 (7,108)
Balance (in Shares) at Apr. 30, 2024   7,458          
Distributions to noncontrolling interests in subsidiaries (240)           (240)
Net income (loss) 16,335     14,791   14,791 1,544
Dividends declared (373)     (373)   (373)  
Net unrealized (gain) loss on interest rate swap contracts (427)       (427) (427)  
Net unrealized loss on investment in U.S. Treasury securities available-for-sale (6)       (6) (6)  
Balance at Jul. 31, 2024 $ 31,822 $ 75 $ 32,215 $ 4,726 $ 610 $ 37,626 $ (5,804)
Balance (in Shares) at Jul. 31, 2024   7,458